상세 보기
Increased Neutrophil to Lymphocyte Ratio is a Poor Prognostic Factor in Patients Undergoing Gemcitabine and Erlotinib Combination Chemotherapy for Pancreatic Adenocarcinoma
Increased Neutrophil to Lymphocyte Ratio is a Poor Prognostic Factor in Patients Undergoing Gemcitabine and Erlotinib Combination Chemotherapy for Pancreatic Adenocarcinoma
- 제목
- Increased Neutrophil to Lymphocyte Ratio is a Poor Prognostic Factor in Patients Undergoing Gemcitabine and Erlotinib Combination Chemotherapy for Pancreatic Adenocarcinoma
- 제목 (타언어)
- Increased Neutrophil to Lymphocyte Ratio is a Poor Prognostic Factor in Patients Undergoing Gemcitabine and Erlotinib Combination Chemotherapy for Pancreatic Adenocarcinoma
- 저자
- HYUN, Jong Jin
- 발행일
- 2015-11-05
- 학회명
- American Pancreas Association 46th Annual Meeting
- 개최지
- San Diego/USA
- 개최국가
- 미국
- 학회 개최일
- 2015-11-04 ~ 2015-11-07